L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis.
CONCLUSIONS: Plasma carnitine metabolism is abnormal in patients on PD, and may be influenced by the PD modality. Given the good tolerability and potential advantages of carnitine used in the PD fluid, L-carnitine-containing solution bags in APD treatment definitely merit further evaluation.
PMID: 24599831 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)